0R

Essity AB (publ)LSE Essity AB Stock Report

Last reporting period 31 Mar, 2024

Updated 13 Nov, 2024

Last price

Market cap $B

19.342

Large

Exchange

XLON - London Stock Exchange

0RQC.L Stock Analysis

0R

Neutral

Based on Eyestock quantitative analysis, 0RQC.L`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

53/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

90.4 %

Greatly undervalued

Market cap $B

19.342

Dividend yield

6.17 %

Shares outstanding

702.34 B

Essity AB engages in the development, production, and marketing of personal care products. The company is headquartered in Stockholm, Stockholm and currently employs 47,572 full-time employees. The company went IPO on 2017-06-15. The firm conducts sales in about 150 countries under such brands, as TENA for incontinence products and Tork for Away-from-Home tissue, as well as under other brands, such as Bodyform, Velvet, Cushelle and Plenty. The Company’s medical brands comprise Leukoplast, Cutimed, JOBST, Delta Cast, Delta Lite and Actimove.

View Section: Eyestock Rating